Triiodothyronine potentiation of fluoxetine in depressed patients
- PMID: 1551045
- DOI: 10.1177/070674379203700111
Triiodothyronine potentiation of fluoxetine in depressed patients
Abstract
Triiodothyronine (T3) has been shown to augment the therapeutic effect of tricyclic antidepressants as well as monoamine oxidase inhibitors. In this report, three cases of T3 potentiation of the antidepressant effect of fluoxetine are described. The results suggest that T3 augmentation may be effective with a wide range of antidepressants.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
